New applications of radioguided surgery in oncology by Bitencourt, Almir Galvão Vieira et al.
397
CLINICS 2009;64(5):397-402
CLINICAL SCIENCE
I
 Department of Image, Hospital AC Camargo - São Paulo/SP, Brazil.
II
 Nuclear Medicine, Hospital AC Camargo - São Paulo/SP, Brazil.
Email: almirgvb@yahoo.com.br
Tel.: 55 11 2189.5000 
Received for publication on November 28, 2008
Accepted for publication on February 03, 2009
NEw AppLICAtIoNS of rAdIoguIdEd SurgEry IN 
oNCoLogy
Almir Galvão Vieira Bitencourt,I Eduardo Nóbrega Pereira Lima,II Paula 
Nicole Vieira Pinto,I Eduardo Bruno Lobato Martins, I Rubens Chojniak I  
 
doi: 10.1590/S1807-59322009000500005
Bitencourt AGV, Lima ENP, Pinto PNV, Martins EBL, Chojniak R. New applications of radioguided surgery in oncology. 
Clinics. 2009;64(5):397-402.
OBJECTIVE: To report oncological cases (excluding those related to breast cancer) for which radioguided surgery has been used 
in combination with the Radioguided Occult Lesion Localization technique. 
INTRODUCTION: Radioguided surgery enables a surgeon to identify lesions or tissues that have been preoperatively marked 
with radioactive substances. The Radioguided Occult Lesion Localization technique has been widely used to identify the sentinel 
lymph node and occult lesions in patients with breast cancer. However, few studies have reported the use of this technique for 
non-breast cancer pathologies. 
METHODOLOGY: In all cases, injection of Technecium-99m sulfur colloid was performed, directly inside or near by the suspi-
cious lesion, guided by ultrasound or computed tomography, up to 36 hours prior to the surgical procedure. Intraoperative lesion 
detection was carried out using a gamma-probe. 
RESULTS: We report five oncology cases in which preoperative markings of the lesions were carried out using the Radioguided 
Occult Lesion Localization technique. The patients presented with the following: recurrence of renal cell carcinoma, cervical recur-
rence of papillary carcinoma of the thyroid, recurrence of retroperitoneal sarcoma, lesions of the popliteal fossa, and recurrence of 
rhabdomyosarcoma of a thigh. In each case, the lesions that were marked preoperatively were ultimately successfully excised. 
CONCLUSIONS: Radioguided surgery has proven to be a safe and effective alternative for the management of oncology patients. 
The Radioguided Occult Lesion Localization technique can be useful in selected cases where suspect lesions may be difficult to 
identify intraoperatively, due to their dimensions or anatomical location. The procedure allows for more conservative excisions and 
reduces the surgery-related morbidity.
KEYWORDS: Radioguided surgery; Radioguided occult lesion localization; Gamma-detecting probe; Surgical Oncology; Tech-
netium Tc 99m Sulfur Colloid.
INTRODUCTION
Radioguided surgery allows a surgeon to identify lesions 
or tissues that have been preoperatively marked with a 
radioactive substance. The intraoperative detection of these 
structures is performed using a gamma-probe, which leads 
to smaller and less traumatic excisions. At present, the main 
clinical application of this surgical technique in oncology is 
to identify the sentinel lymph node and occult lesions or to 
find lesions that are difficult to locate intraoperatively.1
The identification of occult lesions for radioguided 
surgery can be carried out in two ways. The first approach 
consists of systemic administration of a radiocolloid 
associated with a carrier that exhibits tropism for a 
specific tumor or tissue, such as 99mTc-sestamibi for the 
identification of parathyroid adenomas or hyperplasia, 
or 111In-DTPA octreotide for the identification of 
neuroendrocrine tumors.2,3 Under the second approach, the 
lesion to be excised is marked by intratumoral injection of 
the radioisotope, which is guided by an imaging method. 
This technique, known as Radioguided Occult Lesion 
Localization (ROLL), was first described in 1998 for the 
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preoperative localization of occult lesions of the breast.4
The ROLL technique has routinely been used in many 
specialized centers for the preoperative marking of occult 
breast lesions and has demonstrated similar effectiveness 
and various advantages over metallic wire localization.5,6 
However, few studies have reported the use of this technique 
for other pathologies.7 The objective of this work is to report 
oncological cases not related to breast cancer in which 
radioguided surgery has been performed using the ROLL 
technique.
MATERIALS AND METHODS
In this study, we report five oncology cases not related 
to breast cancer in which preoperative marking of lesions 
was performed using the ROLL technique. The patients 
presented suspect lesions identified by imaging methods 
such as ultrasound (US), computed tomography (CT) or 
magnetic resonance imaging (MRI), and positron emission 
tomography/CT (PET-CT) with fluorodeoxyglucose 
(18F-FDG). Since these lesions are difficult to identify 
intraoperatively due to their dimensions or localization, 
radioguided surgery was adopted in all cases.
Injection of 0.1 to 0.2 ml of Technetium 99m sulfur 
colloid (Sn-99mTc) with an activity count of 0.5 to 1.0 
mCi (18.5 to 37 MBq) was administered (guided by US 
or CT) directly into or next to the suspect lesions up to 36 
hours prior to surgery. Immediately after injection of the 
radioactive material, single photon emission computed 
tomography/CT (SPECT-CT) imaging was performed to 
confirm the location and technical quality of the injection. 
The marked lesions were identified intraoperatively using 
a gamma-probe and were excised with safety margins. The 
radioactivity of the tissue was measured in vivo and after 
excision, as well as the radioactivity of the surgical bed, to 
confirm that the marked lesion had been fully excised.
RESULTS
Case 1
Patient ZDF, male, aged 50 years, was admitted with 
a history of right nephrectomy for renal cell carcinoma 
performed eight months previously. CT of the abdomen 
on follow-up identified a hypervascularized heterogeneous 
nodule in the right retroperitoneum, measuring 23 x 18 
mm, and two nodules in the lumbar wall, measuring 8 and 
17 mm (Figure 1A). PET-CT confirmed the presence of 
all lesions on account of high concentrations of 18F-FDG. 
CT-guided percutaneous biopsies were performed and 
revealed suggestive infiltration by clear cell renal carcinoma. 
The patient was then submitted to excision of the lesions 
of the abdominal wall and of the retroperitoneal nodule 
using a gamma-probe to detect the lesions that had been 
preoperatively marked using CT-guided ROLL (Figure 
1B). Surgery lasted for one hour and forty minutes, and 
discharge occurred after five days without complications. 
Histopathological analysis of the surgical specimens 
with immunohistochemistry confirmed the hypothesis of 
recurrence of clear cell renal carcinoma. 
Case 2
NG, female, aged 39 years, was admitted for 
thyroidectomy and right neck dissection for multifocal 
classical papillary carcinoma with lymph node metastasis. 
During the follow-up, an increase of thyrogobulin was 
evidenced, and cervical US identified enlarged lymph nodes 
in the right jugular chain (Level IV), above the subclavian 
veins, measuring 14 mm at their smallest axis. The 
scintigraphy with iodine-131 did not show any alterations, 
but the PET-CT demonstrated an anomalous concentration 
of 18F-FDG in the enlarged right cervical lymph nodes 
Figure 1 - A) Computed tomography of the abdomen without contrast IV injection in the ventral decubitus with nodular imaging in the right renal sinus 
(arrow). B) Moment of CT-guided injection of Sn-99mTc into the lesion
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(Figure 2A). This lesion was excised after preoperative 
localization through CT-guided intralesional injection of 
Sn-99mTc (Figure 2B). The surgery lasted two hours and 
forty minutes. No complications were recorded, and the 
patient was discharged on the first post-operative day. The 
histopathological analysis confirmed metastasis of papillary 
thyroid carcinoma on the cervical lymph node.
Case 3
HHFF, female, aged 63 years, was admitted with 
a history of a high-grade retroperitoneal pleomorphic 
sarcoma that had been treated two years previously with 
neoadjuvant chemotherapy, surgery (monoblock excision of 
the retroperitoneal tumor, psoas muscle, and a segment of 
the left femoral nerve), and intraoperative radiotherapy. Four 
months prior to admission, the patient had undergone video-
assisted excision of a right lung metastasis. In the PET-CT 
control exam, areas of anomalous 18F-FDG concentrations 
were detected in the left iliac fossa, involving the femoral 
nerve stump and infiltrating the oblique muscle, next to the 
iliac, and in the left posterolateral abdominal wall, adhered 
to the end of the 12th rib, adjacent to the lower renal pole. 
CT-guided percutaneous biopsy of the lesion in the iliac 
fossa tested positive for sarcoma. CT-guided Sn-99mTc 
injection was administered in the lesions and was confirmed 
using SPECT-CT (Figure 3) prior to surgery. The patient 
underwent excision of both lesions, using a gamma-probe 
and intraoperative radiotherapy. The surgery lasted four 
hours and thirty-five minutes, and the patient was discharged 
on the seventh post-operative day without complications.
Case 4
LAAR, male, aged 40 years, without any oncological 
history, complained of pain in the distal portion of the thigh 
and edema of the right leg for one month. MRI identified 
two expansive solid formations in the vasculonervous axis 
of the right popliteal fossa, one higher up, measuring 31 
x 25 mm, and the other lower down, measuring 26 x 19 
mm. We decided that surgical treatment with preoperative 
marking of the lesions with ROLL should be performed. 
US-guided injection of Sn-99mTc was performed on the 
lower lesion and was confirmed by SPECT-CT (Figure 
Figure 2 - A) PET-CT demonstrating an anomalous concentration of 18F-FDG in the enlarged right cervical lymph node (maximum SUV: 1.65). B) Moment 
of CT-guided injection of Sn-99mTc into the lesion
Figure 3 - SPECT-CT performed after Sn-99mTc injection into the lesion of the abdominal wall, left side. A) Anatomical image. B) Metabolic image. C) 
Fusion of the two methods
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4). The upper lesion, located approximately 50 mm above 
the lower one, was not marked due to its proximity to the 
popliteal veins. The surgery lasted for two hours and fifteen 
minutes, and the length of the hospital stay was two days. 
There were no immediate post-operative complications. The 
histopathological analysis of both lesions revealed that these 
were schwannomas.
Case 5
SBCP, female, aged 16 years, with a history of tumors 
of the left thigh, submitted to extended excision one year 
ago, for which the histological diagnosis was embryonic 
rhabdomyosarcoma. Six months ago, the patient underwent 
marginal excision of recurrence in the topography of the 
left femoral vein. In the oncological follow-up, PET-CT 
was performed, evidencing an anomalous concentration 
of 18F-FDG in the topography of the subcicatricial nodule 
deep in the left thigh. The lesion was marked with US-
guided injection of Sn-99mTc and confirmed by SPECT-CT 
(Figure 5). The patient subsequently underwent radioguided 
marginal excision. Surgery took about two hours and forty 
minutes without complications. The patient was discharged 
on the second post-operative day. The histopathological 
analysis confirmed undifferentiated round cell neoplasia 
infiltrating soft parts, compatible with a recurrence of 
rhabdomyosarcoma.
DISCUSSION
The ROLL technique used in these patients was effective 
in the intraoperative localization of the marked lesions, 
demonstrating that this is a feasible and promising technique 
for the surgical exploration of selected cases. This technique 
does not have any side effects, requires minimal radiation, 
and enables less invasive procedures with a lower level of 
post-operative complications. The approach reduces surgery 
time and shortens a patient’s hospital stay.8
Technical precautions at the moment of administration 
of the radiocolloid and at the time of preoperative imaging 
Figure 4 - SPECT-CT performed after Sn-99mTc injection in the lesion of the right popliteal fossa. A) Anatomical image. B) Metabolic image. C) Fusion 
of the two methods
Figure 5 - SPECT-CT carried out after Sn-99mTc injection in the left abdominal lesion. A) Anatomical image. B) Metabolic image. C) Fusion of the two 
methods
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are essential for guaranteeing the intraoperative localization 
without complications. The preoperative image is important 
for confirming the technical quality of the injection, ruling 
out the possibility of leakage, contamination involving the 
skin, and residual activity in the path of the needle. This 
imaging should preferably be carried out with SPECT-CT, 
which enables simultaneous observation of the distribution of 
the radiocolloid and its precise anatomical location provided 
by a CT device coupled with a SPECT gamma-camera.
Despite being used successfully in cases of occult breast 
lesions, the ROLL technique has been rarely described in 
other oncological pathologies. Gulec et al. (2007) describe 
three non-habitual oncology cases, in which radioguided 
surgery was carried out after injection of an albumin 
macroaggregate following the US- or endoscopy-guided 
injection of 99mTc. In two of these cases, the surgical 
indication was for the diagnostic investigation of suspect 
enlarged lymph nodes, one axillary in a patient with a history 
of breast cancer, and the other mediastinal in a patient with 
a history of non-Hodgkin’s lymphoma. In the third case, the 
surgical indication was to determine the extent of the surgical 
excision in a patient with colonic polyposis.7
In cases of cervical recurrence of well-differentiated 
thyroid cancer, some authors have demonstrated good results 
with radioguided surgery following systemic administration 
of iodine-131.9,10 However, in cases where the lesion does 
not concentrate iodo-131 in the scintigraphy, as in the second 
case presented here, this methodology is ineffective. Other 
authors have also reported a successful use of the ROLL 
technique in patients with recurrence of thyroid cancer in 
non-palpable cervical lymph nodes.11,12
In four of the five cases presented, the lesions were 
identified preoperatively by PET-CT. With the growing use 
of this method in the evaluation of oncological patients, 
some authors have described techniques for intraoperative 
localization of recurring or metastatic lesions identified 
by the PET-CT.13-16 Given that 18F-FDG has a short half-
life of around two hours, the systemic injection of this 
radiocolloid should be carried out immediately before 
surgery. Furthermore, as the photons liberated by the 
18F-FDG have 511 keV of energy, compared with 140 keV 
for photons liberated by 99mTc, it is necessary to use a specific 
high-energy gamma-probe.17 However, this methodology 
requires further study to prove its effectiveness. The ROLL 
technique therefore provides an interesting alternative for the 
intraoperative localization of these lesions.
Other recently described applications of the ROLL 
technique include localization of pulmonary nodules during 
thoracoscopy 18,19 and identification of non-palpable colonic 
lesions during open or laparoscopic surgery following 
colonoscopy-guided radiocolloid injection.20
CONCLUSIONS
Radioguided surgery has proven to be a feasible and 
promising alternative for the management of oncological 
patients. The ROLL technique may be useful in selected 
cases where the suspect lesions are difficult to identify 
intraoperatively due to their dimensions or anatomical 
location, enabling more conservative excisions and reducing 
the morbidity related to surgery. 
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